Home NDC 72850-0007-2 Cebashin Cap.
Product NDC 72850-0007
Requested package NDC 72850-0007-2
11-digit product format 728500007
Labeler code 72850
Product ID 72850-0007_d6e992e3-5ca4-17fe-e053-2a95a90ae31b
Type HUMAN OTC DRUG
Nonproprietary name FORSYTHIA SUSPENSA FRUIT, LONICERA JAPONICA WHOLE, MENTHA ARVENSIS TOP, PLATYCODON GRANDIFLORUS ROOT, LICORICE, ARCTIUM LAPPA FRUIT, GLYCINE MAX WHOLE, LOPHATHERUM GRACILE TOP, SCHIZONEPETA TENUFOLIA SPIKE, SAIGA TATARICA HORN
Dosage form CAPSULE
Route ORAL
Labeler Chunwoo Pharmaceutical Co., Ltd.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2022-01-12
Marketing end 0000-00-00
Substance ARCTIUM LAPPA FRUIT; FORSYTHIA SUSPENSA FRUIT; GLYCINE MAX WHOLE; LICORICE; LONICERA JAPONICA WHOLE; LOPHATHERUM GRACILE TOP; MENTHA ARVENSIS TOP; PLATYCODON GRANDIFLORUS ROOT; SAIGA TATARICA HORN; SCHIZONEPETA TENUFOLIA SPIKE
Active strength 356 mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72850-0007-1 Cebashin Cap. 10 g in 1 CAPSULE CAPSULE 10 2 72850-0007-2 Cebashin Cap. 1 in 1 BOX CAPSULE 1 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72850-0007 CEBASHIN CAP. (FORSYTHIA SUSPENSA FRUIT, LONICERA JAPONICA WHOLE, MENTHA ARVENSIS TOP, PLATYCODON GRANDIFLORUS ROOT, LICORICE, ARCTIUM LAPPA FRUIT, GLYCINE MAX WHOLE, LOPHATHERUM GRACILE TOP, SCHIZONEPETA TENUFOLIA SPIKE, SAIGA TATARICA HORN) CAPSULE [CHUNWOO PHARMACEUTICAL CO., LTD.] 2 Legacy NDC, 2 package rows 20220201_d3c1a869-be57-38a4-e053-2995a90a0d62.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 72850-0007-2 72850000702 1 CAPSULE in 1 BOX (72850-0007-2) > 10 g in 1 CAPSULE (72850-0007-1) 1 capsule 2022-01-12 0000-00-00 No No Current